Format

Send to:

Choose Destination
See comment in PubMed Commons below
Neurotherapeutics. 2013 Oct;10(4):817-30. doi: 10.1007/s13311-013-0210-9.

Chromatin modifications associated with DNA double-strand breaks repair as potential targets for neurological diseases.

Author information

  • 1The Burke Medical Research Institute, 785 Mamaroneck Avenue, White Plains, NY, 10605, USA, cab2026@med.cornell.edu.

Abstract

The integrity of the genome is continuously challenged by both endogenous and exogenous DNA damaging agents. Neurons, due to their post-mitotic state, high metabolism, and longevity are particularly prone to the accumulation of DNA lesions. Indeed, DNA damage has been suggested as a major contributor to both age-associated neurodegenerative diseases and acute neurological injury. The DNA damage response is a key factor in maintaining genome integrity. It relies on highly dynamic posttranslational modifications of the chromatin and DNA repair proteins to allow signaling, access, and repair of the lesion. Drugs that modulate the activity of the enzymes responsible for these modifications have emerged as attractive therapeutic compounds to treat neurodegeneration. In this review, we discuss the role of DNA double-strand breaks and abnormal chromatin modification patterns in a range of neurodegenerative conditions, and the chromatin modifiers that might ameliorate them. Finally, we suggest that understanding the epigenetic modifications specific to neuronal DNA repair is crucial for the development of efficient neurotherapeutic strategies.

PMID:
24072514
[PubMed - indexed for MEDLINE]
PMCID:
PMC3805873
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Write to the Help Desk